Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. - Wikidata - awgldk - TriplyDB

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.

http://www.wikidata.org/entity/Q30989699

about

Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells Protein and Chemical Microarrays—Powerful Tools for Proteomics Genetic alteration and gene expression modulation during cancer progression Application of protein lysate microarrays to molecular marker verification and quantification Reverse phase protein arrays in signaling pathways: a data integration perspective New approaches to understanding the immune response to vaccination and infection Emerging protein array technologies for proteomics Overview of protein microarrays Facing current quantification challenges in protein microarrays Functional protein microarray as molecular decathlete: a versatile player in clinical proteomics One-step preservation of phosphoproteins and tissue morphology at room temperature for diagnostic and research specimens Analysis of Reverse Phase Protein Array Data: From Experimental Design towards Targeted Biomarker Discovery Reverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical Use Laser capture microdissection technology Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines Biomarkers in cancer staging, prognosis and treatment selection Reverse phase protein microarrays advance to use in clinical trials Udp-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters Receptor tyrosine kinase (RTK) mediated tyrosine phosphor-proteome from Drosophila S2 (ErbB1) cells reveals novel signaling networks Human cell chips: adapting DNA microarray spotting technology to cell-based imaging assays Receptor tyrosine kinases fall into distinct classes based on their inferred signaling networks Discovery of new molecular subtypes in oesophageal adenocarcinoma Proteomics and mass spectrometry for cancer biomarker discovery Reduced PARP1 as a Serum Biomarker for Graft Rejection in Kidney Transplantation Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.The use of proteomics to identify novel therapeutic targets for the treatment of disease.Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition.A high-throughput assay for phosphoprotein-specific phosphatase activity in cellular extracts.Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial.Elevated TNFR1 and serotonin in bone metastasis are correlated with poor survival following bone metastasis diagnosis for both carcinoma and sarcoma primary tumors.Improved data normalization methods for reverse phase protein microarray analysis of complex biological samples.Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.Phosphoprotein stability in clinical tissue and its relevance for reverse phase protein microarray technology.TMA Navigator: Network inference, patient stratification and survival analysis with tissue microarray data Asymmetric cancer cell division regulated by AKT Functional genomics studied by proteomics.A comprehensive comparison of normalization methods for loading control and variance stabilization of reverse-phase protein array data.Spatial normalization of reverse phase protein array data.Contributions of proteome profiling to the molecular analysis of cancer.

P2860

Q24562089-8A4B764E-A55C-4276-9880-CEC968244BC2 Q24798712-E8535833-474C-46BE-9C58-E0375964A083 Q24798750-8AF539EE-3EB9-42BA-A986-B1F65C61EF80 Q25257533-3CA46E94-D4EB-435B-8527-E51A4A77A18A Q26799716-64260A3A-A350-44FB-99CE-67695CB268DA Q26800283-101E941B-9FAF-4A2A-9300-9B874F720BB1 Q26824107-9D6D286E-187D-4CB6-8E72-F13DCBB50A68 Q26830244-9FDD2048-88FB-490B-8EA3-91DE0D2D2C28 Q26864708-DB5E3010-3D1E-42A8-B1EF-F3DC33594C81 Q27025953-6B90E0C4-6749-4700-87D2-9B6A36779DD8 Q27323289-D2FBE98B-47E7-4841-A411-FD41759E2514 Q28080766-1A670B91-1762-4315-9BE3-992060FF3C71 Q28083256-DC5D0A74-446D-439F-9A67-6237F6D06CFD Q28250373-255A14BD-56B0-4FA1-9825-299B2425D38E Q28259553-4ACD6CB1-FC1A-4DA7-812B-D6638031CB2D Q28278305-AFC2D0C0-0D9B-417F-A9B1-4B7AB593A7A1 Q28384553-262D8D52-EDBC-467B-B75E-E3B0B1679DDE Q28392741-F3067C6C-3550-40CF-95CB-FF765CAEC807 Q28396602-69ECE7D5-315F-4F71-9D9C-8A0AEA000DCE Q28473351-A3F8179B-ACE8-4D62-B3BF-8A75E9E1CB89 Q28476327-043F42EC-3062-44E4-8A2D-019F98F57A99 Q28537891-60179BEA-2F48-4523-BFAE-D7FC0F623843 Q28744610-A7938329-03E4-4CF6-91CF-97EAC314129B Q28766969-02330E2A-B88D-469B-BC3A-2283E7336161 Q30177456-D7C52D9F-926D-4282-967A-A4EB63AB424D Q30278883-0B880DC8-A76A-4B5C-93A0-25D482D4FD9B Q30361936-17C04729-4004-4964-B6F3-318E382E65D3 Q30414265-48046BFF-96E8-40E5-829E-05310F1C5E73 Q30414621-2BC4D51E-2EC0-4B32-AE6D-3C85CD8D685C Q30429122-12A412D2-8630-4E5E-BEAA-09505A5A81E9 Q30439048-2996D813-4E01-434C-8FE2-1331CF61FA09 Q30449408-314F718F-058A-4AE3-8F60-39555DE8557B Q30449558-1EBF380C-A95B-487D-8B51-0BD839FE66FA Q30450696-6FFD6634-D3E2-4F9F-9272-B8CEEF9ACA2E Q30486190-426E1E71-19A8-4B1E-BF1F-2414921367A5 Q30503288-578EEA76-EED6-4DBB-A198-014E73FDD6A7 Q30765248-C135CD44-E4E7-4155-8234-4E38AE7A3046 Q30867943-CD8E224A-3EEE-4121-B7E9-B743E0B21515 Q30877911-D47E39B1-1DBE-4EF2-B83D-612654FB4E55 Q30893357-8B16E7AD-B456-403D-B65F-9ED495F80748

P2860

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.

http://www.wikidata.org/entity/Q30989699

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Reverse phase protein microarr ...... at the cancer invasion front.

@ast

Reverse phase protein microarr ...... at the cancer invasion front.

@en

type

label

Reverse phase protein microarr ...... at the cancer invasion front.

@ast

Reverse phase protein microarr ...... at the cancer invasion front.

@en

prefLabel

Reverse phase protein microarr ...... at the cancer invasion front.

@ast

Reverse phase protein microarr ...... at the cancer invasion front.

@en

P1433

Q30989699-9F234203-6100-4EA3-99EF-E863AA427D3A

P1476

Q30989699-7785615E-3069-4681-B8E7-243F0B8E6833

P2093

Q30989699-0C53D29B-A444-405A-BB49-A7825A395FCC

Q30989699-2D715F08-E45D-4119-ADA6-BFFC762447B3

Q30989699-34A59D21-6DF0-401A-B5AA-3A3256077209

Q30989699-36219A64-D431-466A-8274-0C617CC34BAA

Q30989699-44C185DF-012B-4731-8CEC-A0F848E6B609

Q30989699-4C6C0EE3-A053-4180-AA81-9F77C4F60D13

Q30989699-6A379F31-6E77-4FA8-95B4-2BC1699FF80A

Q30989699-A8407DDA-F9C5-4373-BAAE-D9F5C49427DB

Q30989699-E3921BE3-7C48-4ABA-861C-772D31190CE7

Q30989699-F8658B3E-853F-4A09-814A-65F236E0CBB4

P2860

Q30989699-095C4D76-B332-41A3-A43A-7C38F04BF2D7

Q30989699-10EF39FC-22CB-4C3B-B759-BD0094ACC865

Q30989699-3F339BB0-29A9-4B13-A099-C607D26B9CDD

Q30989699-413C82C0-6F93-4B93-AC06-F85EFF289A79

Q30989699-42F7FD89-4203-43B4-A275-593A934685F7

Q30989699-47E2C987-4EA6-41A4-873F-16573F3E2FE3

Q30989699-53E01267-0882-49E6-ACE4-71DC453612A3

Q30989699-548FCD90-82B3-49C4-B102-F0ADB9A3B9F3

Q30989699-5660C0A4-5269-4067-A16B-EF462F1F190D

Q30989699-60F7FD48-B503-4309-830F-484B5E527EE9

P2888

Q30989699-39D0A847-F2FD-4EEC-893A-B4CAA2B1F1AC

P304

Q30989699-27A0113A-C898-41E2-8344-D2B88A6418DA

P31

Q30989699-115805BC-66CD-40D3-88AC-29984579124B

P356

Q30989699-618FB462-41D9-44E5-A0E0-754595A52E41

P407

Q30989699-BB535811-8EE1-4737-BD33-95C1A55C918E

P433

Q30989699-9A0F69B6-9D60-4094-8DCF-437B9023C606

P478

Q30989699-4B800101-8A56-406A-86AB-9450924BCCBA

P577

Q30989699-D6C6594B-9956-4538-B1A4-1326FD68A09F

P5875

Q30989699-AE9A020A-7CA9-494F-A538-B5D4379B89D6

P6179

Q30989699-667F7101-74BD-46C2-A7BA-C3F7EC338159

P698

Q30989699-F2C774DE-6547-4B8A-B8E2-79D2803E7A3D

P356

P1433

P1476

Reverse phase protein microarr ...... at the cancer invasion front.

@en

P2093

Bichsel VE

http://www.w3.org/2001/XMLSchema#string

Charboneau L

http://www.w3.org/2001/XMLSchema#string

Chen T

http://www.w3.org/2001/XMLSchema#string

Emmert-Buck MR

http://www.w3.org/2001/XMLSchema#string

Gillespie JW

http://www.w3.org/2001/XMLSchema#string

Liotta LA

http://www.w3.org/2001/XMLSchema#string

Paweletz CP

http://www.w3.org/2001/XMLSchema#string

Petricoin III EF

http://www.w3.org/2001/XMLSchema#string

Roth MJ

http://www.w3.org/2001/XMLSchema#string

Simone NL

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

Phosphorylation and regulation of Raf by Akt (protein kinase B)

Laser capture microdissection

High density synthetic oligonucleotide arrays

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Protein microarrays for gene expression and antibody screening.

Large-scale functional analysis using peptide or protein arrays.

P2888

P304

1981-1989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1204265

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11978315

http://www.w3.org/2001/XMLSchema#string

P6179

1040378214

http://www.w3.org/2001/XMLSchema#string

P698

11360182

http://www.w3.org/2001/XMLSchema#string